{Ifinatamab, | This promising therapeutic agent , | The investigational therapeutic, is attracting increasing attention due to its specific mechanism of action . This therapy specifically engages with B7-H3, a cell molecule overexpressed within a range of cancer cells . Preliminary preclinical data indicate promising activity in treating diverse sp